SCNDOTCLaboratory Analytical InstrumentsFiscal year ends December 31
SCIENTIFIC INDUSTRIES INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.68+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $8.16M
- P/E (TTM)
- –
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2010 to 2025
Gross margin
25.8%−17.0 pts over 5 years
Operating margin
-156.1%−163.7 pts over 5 years
Net margin
-24.1%−30.5 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +5.4% | -23.8% | -8.3% | -4.3% | |
| Gross profit | -35.1% | -39.0% | -19.8% | -8.4% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2015 | FY2019 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 0.2% | 10.7% | -12.3% | |
| Return on assets | 0.1% | 8.3% | -10.1% | |
| Current ratio | 4.02 | 4.16 | 7.70 | |
| Interest coverage | -4.0× | 517.4× | – | |
| Inventory turnover | 2.1× | 2.4× | 2.0× | |
| Capex to revenue | 0.9% | 1.8% | 1.3% | |
| Diluted shares | 1M | 2M | 11M |
Where the cash went
Fiscal 2020 to 2025, five years combined
Scientific Industries generated $20.13M from operations and spent $1.17M on capital expenditure, dividends and share buybacks. 100% of that went back into the business.
Generated
$20.13M
Used
$1.17M
Capital expenditure$1.17M100%Dividends$00%Share buybacks$00%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin-24.1%
×Asset turnover0.42×
×Equity multiplier1.22×
=Return on equity, FY2025-12.3%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | -24.1% | 0.42× | 1.22× | -12.3% |
| FY2022 | -119.9% | 0.46× | 1.14× | -62.5% |
| FY2021 | -37.6% | 0.45× | 1.15× | -19.4% |
| FY2020 | -9.0% | 0.67× | 1.28× | -7.8% |
| FY2019 | 6.3% | 1.31× | 1.30× | 10.7% |
| FY2018 | -1.9% | 1.20× | 1.23× | -2.8% |
| FY2017 | -0.9% | 1.13× | 1.22× | -1.2% |
| FY2016 | 1.7% | 1.31× | 1.26× | 2.8% |
| FY2015 | 0.1% | 1.10× | 1.25× | 0.2% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
1of 6 tests passed in fiscal 2025. Some tests lack the figures they need.
- ProfitableNet income above zero-$1.22M
- Cash generatingOperating cash flow above zero-$8.15M
- Return on assets improvedROA up on the prior year– → -10.6%
- Earnings backed by cashOperating cash flow above net income-$8.15M vs -$1.22M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose4.74 → 7.70
- No dilutionShare count did not rise11M → 11M
- Gross margin improvedGross margin up on the prior year41.83% → 25.78%
- More efficientAsset turnover rose– → 0.44